How to deal with multiple treatment or dose groups in randomized clinical trials? Another approach
暂无分享,去创建一个
The multiple test issue is a tricky one. There is no entirely correct solution. It is better to avoid it by careful thinking prior to beginning the experiment. In fundamental and clinical pharmacology, there are several established concepts that allow researchers to minimize the cases where the issue arises.
[1] L A Hothorn,et al. How to deal with multiple treatment or dose groups in randomized clinical trials? , 2007, Fundamental & clinical pharmacology.